To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects

Phase 1

Not yet recruiting

• Conditions: Healthy
• Interventions: Drug: DA-5222

• Registration Number: NCT06993168
• Lead Sponsor: Dong-A ST Co., Ltd.

Brief Summary

This study is to evaluate the effect of food on pharmacokinetics of DA-5222 in healthy adult subjects

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-05
• Study First Submitted: 2025-05-19
• Study First Submitted QC: 2025-05-19
• Last Update Submitted: 2025-05-19
• Study Start: 2025-05-21
• Study First Posted: 2025-05-28
• Last Update Posted: 2025-05-28
• Primary Completion: 2025-07
• Study Completion: 2025-07

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Healthy volunteers
• BMI between 18 and 30 kg/m2
• Body weight: Male≥50kg, Female≥45kg
• Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study

Exclusion Criteria

• Subjects with clinically significant medical history
• Subjects with history of drug abuse or addicted
• Subjects with allergy or drug hypersensitivity

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Sequence A	DA-5222	-
Sequence B	DA-5222	-

Primary Outcome Measures

Name	Time	Method
AUCt	pre-dose~72 hours post-dose	area under the curve
Cmax	pre-dose~72 hours post-dose	maximum plasma concentration

Trial Locations

Locations (1)

Bumin Hospital; 🇰🇷 Seoul, South Korea, Korea, Republic of